Literature DB >> 23931016

The role of surgery in patients with clinical n2 disease.

Reza Mehran1.   

Abstract

Patients with N2 non-small cell lung carcinoma have ipsilateral mediastinal adenopathy with stage IIIA disease. Most of these patients are still staged solely using imaging techniques, which causes a significant error in staging if not combined with some form of surgical staging of the mediastinum. N2 disease forms a spectrum of disease ranging from occult microscopic disease to bulky multistation adenopathy. Proper understanding of the prognosis and treatment implications for each form of mediastinal lymph node metastases has led to the selective use of surgery to treat these patients. This article reviews the role of surgery in the management of patients with N2 mediastinal involvement.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Metastatic mediastinal lymph node; Non–small lung carcinoma; Radiation therapy; Surgery

Mesh:

Year:  2013        PMID: 23931016     DOI: 10.1016/j.thorsurg.2013.04.007

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  2 in total

1.  Clinicopathologic correlates of postoperative N1 or N2 nodal upstaging in non-small cell lung cancer.

Authors:  Youngkyu Moon; Kyo Young Lee; Kyung Soo Kim; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

2.  Prognostic Value of Tumor Size in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer.

Authors:  Chih-Yu Chen; Bing-Ru Wu; Chia-Hung Chen; Wen-Chien Cheng; Wei-Chun Chen; Wei-Chih Liao; Chih-Yi Chen; Te-Chun Hsia; Chih-Yen Tu
Journal:  J Clin Med       Date:  2020-05-01       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.